Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 25 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/01/20
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 11/30/06
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 01/31/20
Due: 01/31/21
Phase: N/A
Priority: Normal
Start: 02/28/06
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 10/31/16
End: 09/30/21
Due: 09/30/22
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 08/01/17
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 03/31/11
Due: 03/31/12
Phase: N/A
Priority: Normal
Start: 04/30/05
End: 02/29/08
Due: 02/28/09
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 11/30/13
Due: 11/30/14
Phase: N/A
Priority: Normal
Start: 06/30/13
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 02/28/17
Due: 02/28/18
Phase: N/A
Priority: Normal
Start: 08/31/07
End: 08/31/15
Due: 08/31/16
Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer.
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 11/30/06
End: 02/28/09
Due: 02/28/10
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 04/30/02
End: 04/30/08
Due: 04/30/09
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 02/29/20
Due: 02/28/21
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 12/01/17
End: 11/30/21
Due: 11/30/22
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 03/31/14
Due: 03/31/15